ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $799,000 | -10.4% | 67,842 | +3.8% | 0.01% | -9.1% |
Q1 2019 | $892,000 | +154.9% | 65,340 | +113.5% | 0.01% | +175.0% |
Q2 2017 | $350,000 | -45.1% | 30,610 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $637,000 | 0.0% | 30,610 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $637,000 | -36.5% | 30,610 | 0.0% | 0.01% | -38.5% |
Q3 2016 | $1,003,000 | +31.3% | 30,610 | 0.0% | 0.01% | +30.0% |
Q2 2016 | $764,000 | +67.9% | 30,610 | +64.8% | 0.01% | +66.7% |
Q1 2016 | $455,000 | -25.8% | 18,570 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $613,000 | – | 18,570 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |